Voxelotor Oral Tablet

DRUG2 trials

Sponsors

Pfizer

Conditions

Leg UlcersSickle Cell Disease

Phase 3

Resolution of Sickle Cell Leg Ulcers With Voxelotor

TerminatedNCT05561140

PfizerLeg Ulcers, Sickle Cell Disease

Start: 2022-05-30End: 2024-10-22Updated: 2025-07-09

Phase 4

Voxelotor Brain Oxygenation and Neurocognitive Study

WithdrawnNCT05228821

PfizerSickle Cell Disease

Start: 2023-08-09End: 2023-08-23Updated: 2024-08-09

Related Papers

The Effect of Tucaresol on Translational MRI Estimates of Cerebral Physiology in Townes SCD Mice

Blood2023-11-02

Trials in Progress: Two Randomized, Double-Blind, Multicenter, Placebo-Controlled Trials Investigating the Efficacy of Voxelotor on Cerebral Blood Flow and Neurocognitive Function in Patients with Sickle Cell Disease

Blood2022-11-15